目的研究活体肝移植治疗重型肝炎的疗效。
Objective To evaluate the effect of living donor liver transplantation on the treatment of severe hepatitis.
结论：血浆置换是一种治疗重型肝炎的有效方法。
Conclusion: Plasma exchange is an effective therapeutic means for severe hepatitis.
结论活体肝移植术是治疗重型肝炎的有效方法之一。
Conslusion Living donor liver transplantation is one of effect ways for the treatment of severe hepatitis.
目的：评价选择性血浆置换治疗重型肝炎的临床疗效。
Objective To evaluate the clinical efficacy of a selected plasma exchange artificial liver support system in the treatment of severe hepatitis.
目的评价人工肝支持系统中血浆置换治疗重型肝炎的疗效。
Objective To evaluate the curative effect of plasma-exchange therapy for severe hepatitis in artificial liver system.
目的探讨头孢吡肟治疗重型肝炎肝移植术后细菌感染的疗效。
Objective To evaluate the efficacy and safety of cefepime in the treatment of bacterial infection in severe hepatitis patients after liver transplantation.
目的观察中西药结合人工肝技术治疗重型肝炎63例的临床疗效。
Objective:To observe the effect of the artificial liver technique and the combination of TCM and WM for 63 patient of heavy type hepatitis.
结论血浆置换术治疗重型肝炎疗效肯定，在早、中期治疗效果好。
Conclusion Plasma exchange is effective in treatment of severe hepatitis, in early and middle stages can obtain a better results.
目的：了解血液灌流联合连续性血液滤过治疗重型肝炎的临床效果。
Objective: To investigate the clinical efficacy of hemoperfusion combined with continuous hemofiltration in treatment of severe hepatitis.
结论低置换量血浆置换联合血浆吸附治疗重型肝炎是一种有效的方法。
Conclusion the plasma exchange with plasma absorption is an effective treatment for the severe hepatitis patients.
目的：观察结肠途径治疗机配合中西医结合治疗重型肝炎的临床疗效。
Objective: to observe the efficiency of using colon therapy system to cure severe viral hepatitis.
目的观察非生物型人工肝治疗重型肝炎后生化指标的改善与预后的关系。
Objective to observe the relationship between improved biochemical indicators and prognosis among severe hepatitis patients after artificial liver treatment.
目的探讨人工肝支持系统(ALSS)治疗重型肝炎的护理问题和护理措施。
Objective Make an inquiry into the nursing problems and nursing methods of artificial liver supporting systems (ALSS) treatment of fatal hepatitis.
目的：研究新综合疗法治疗重型肝炎的临床价值。方法：进行临床对照研究。
Objective: To explore the clinical value of treatment on patients with heavy hepatitis by using new integration therapeutics.
目的分析MARS(分子吸附再循环系统)治疗重型肝炎的疗效及影响因素。
To analyze the treatment effects of the molecular adsorbent recycling system (MARS) for severe hepatitis and the related factors.
目的探讨应用两种不同血管通路进行血浆置换治疗重型肝炎的疗效，及两种方法对治疗的影响。
Objective To investigate the influence of plasma exchange (PE) for treating severe hepatitis by two different vascular accesses.
新综合疗法组显效者退黄时间少于旧法组。结论：治疗重型肝炎之新综合疗法方案较为全面、合理。
Conclusions: the new integration therapeutics is more completely and reasonable in the treatment of patients with heavy hepatitis.
目的观察HA中性大孔树脂血浆吸附治疗重型肝炎肝性脑病的治疗效果，探讨肝性脑病新的治疗方法。
Objectives: the aim of this study is to evaluate the therapeutic effectiveness of plasma adsorption with ha microporous resin in patients of severe hepatitis with hepatic encephalopathy.
结论：人工肝血浆置换术是治疗重型肝炎病人一种安全、有效的治疗方法，可明显提高病人的存活率。
Conclusion: Artificial liver plasma replacement to heavy-duty hepatitis patient treatment is a safe and effective treatment method, which could evidently improve the patient's survival rate.
结论MARS是治疗重型肝炎的有效方法，其疗效与患者年龄、重型肝炎的临床分型及分期有关，与MARS治疗次数不呈正相关。
Conclusion MARS is effective in treating severe hepatitis, which is related to the age of patients and the clinical type and stage of severe hepatitis but not to the treatment times.
目的评价分子吸附再循环系统(MARS)治疗重型肝炎的临床疗效，应用终末期肝病评分模型(MELD)，观察它对重型肝炎预后的预测作用。
Objective to evaluate the efficiency of Molecular Adsorbents Recycling System (MARS) in the treatment of severe hepatitis and to study the clinical use of the Model for End-Stage Liver Diease (MELD).
目的探讨膦甲酸钠治疗慢性重型乙型肝炎的疗效及其不良反应。
To observe the clinical effect and adverse effect of foscarnet sodium in treating patients with chronic severe hepatitis B.
结论：血浆置换是一种有效的人工肝支持疗法，对慢性重型肝炎有肯定和可靠的辅助支持与治疗作用。
Conclusions: the plasma exchange is a kind of effective artificial liver support therapy, having affirmative and dependable effect of support and treatment in patients with chronic severe hepatitis.
目的：探讨慢性重型病毒性肝炎患者低钠血症的治疗。
Objective: To discuss the treatment of viral chronic severe hepatitis with hyponatremia.
目的评估膦甲酸钠联合人工肝支持系统治疗重型乙型肝炎的临床价值。
Objective To estimate the clinical value of combination of PFA with ALSS in the treatment of SHB.
结论所建混合生物人工肝支持系统对肝衰竭有明显的肝支持作用，可作为重型肝炎的有效治疗手段。
Conclusions the hybrid artificial liver support system has prominent liver support effects for hepatic failure, which can be regarded as an efficient measure for the treatment of severe hepatitis.
目的科学、准确地预测重型病毒性肝炎患者的预后，为临床治疗决策提供科学依据。
Objective To predict scientifically and accurately the prognosis of patients with severe viral hepatitis, and provide a scientific basis for judgment of clinical treatment.
目的探讨预防性抗菌治疗对重型病毒性肝炎患者自发性细菌性腹膜炎(sbp)的发生及疗效的影响。
Objective to explore the effect of preventive antibacterial treatment on spontaneous bacterial peritonitis (SBP) in the patients with severe hepatitis.
方法将72例重型肝炎患者随机分为治疗组和对照组，比较两组的临床疗效。
Methods 72 patients with severe hepatitis were randomly divided into the trial group and the control group.
结论优思弗联合人工肝治疗慢性重型肝炎是安全和有效的。
Conclusion Ursofalk combined with artificial liver treatment and conventional therapy is safe and more effective in treatment of chronic severe hepatitis.
应用推荐